Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators

被引:5
|
作者
Lemini, Riccardo [1 ]
Vico, Tamara Diaz [1 ]
Trumbull, Denslow A. [2 ]
Attwood, Kristopher [3 ]
Spaulding, Aaron C. [4 ]
Elli, Enrique F. [1 ]
Colibaseanu, Dorin T. [1 ]
Kukar, Moshim [5 ]
Gabriel, Emmanuel [1 ]
机构
[1] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Roswell Park Comprehens Canc Ctr, Dept Biostat, Buffalo, NY USA
[4] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA
[5] Roswell Park Comprehens Canc Ctr, Dept Surg Oncol, Buffalo, NY USA
关键词
Esophageal cancer; overall survival (OS); calculator; nomogram; neoadjuvant chemoradiation; BODY-MASS INDEX; NEOADJUVANT CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; PREDICTS SURVIVAL; COLON-CANCER; LYMPH-NODES; SURGERY; ADENOCARCINOMA; NOMOGRAM; CHEMORADIATION;
D O I
10.21037/jgo-20-337
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the best approach for esophageal cancer and predicting accurate prognosis are critical. Multiple studies evaluated characteristics associated with overall survival, and several prediction models have been developed. This study aimed to evaluate existing models and perform external validation of selected models. Methods: A retrospective investigation of a multi-site institutional enterprise for patients with a diagnosis of esophageal cancer between 2013-2014 was performed. Selected survival prediction models included the Roswell Park Comprehensive Cancer Center (RPCCC) calculator, Oregon Health & Science University (OHSU) calculator, and two nomograms published by Shapiro et al. and Sun et al. One-year overall survival, level of agreement, and performance for each model were evaluated. Results: A total of 104 patients were included and used to assess the prediction models. One-year overall survival was 0.76. Different calculators tended to rank patients similarly; however, they did not agree on predicted overall survival. The least disparity in correlation was observed between OHSU and Shapiro calculators. Shapiro's model achieved the highest performance [area under the curve (AUC) =0.63]. Conclusions: Selected models showed fair results in estimating individual overall survival, although none achieved a high performance. While these tools may support the decision-making process for esophageal cancer patients, their implementation in clinical practice requires improved refinement to optimize their clinical utility.
引用
收藏
页码:1963 / 1972
页数:10
相关论文
共 50 条
  • [41] Concomitant chemoradiotherapy in women with stage I-III breast cancer.
    Arnoldo Richardet, Eduardo
    Laura, Perelli
    Eduardo Richardet, Martin
    Castagneris, Nicolas
    Nicolas Cortes, Matias
    Molina, Matias
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Treatment of stage I-III rectal cancer: Who is refusing surgery?
    Fields, Adam C.
    Lu, Pamela W.
    Yoo, James
    Irani, Jennifer
    Goldberg, Joel E.
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (06) : 990 - 1000
  • [43] Compromised Margins Following Mastectomy for Stage I-III Breast Cancer
    Al Mushawah, Fatema
    Aft, Rebecca L.
    Gillanders, William E.
    Eberlein, Timothy J.
    Margenthaler, Julie A.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S162 - S162
  • [44] Impact of delay to surgery on survival in stage I-III colon cancer
    Grass, Fabian
    Behm, Kevin T.
    Duchalais, Emilie
    Crippa, Jacopo
    Spears, Grant M.
    Harmsen, William S.
    Hubner, Martin
    Mathis, Kellie L.
    Kelley, Scott R.
    Pemberton, John H.
    Dozois, Eric J.
    Larson, David W.
    EJSO, 2020, 46 (03): : 455 - 461
  • [45] Metastatic relapse of stage I-III breast cancer in New Zealand
    Lao, Chunhuan
    Kuper-Hommel, Marion
    Elwood, Mark
    Campbell, Ian
    Lawrenson, Ross
    CANCER CAUSES & CONTROL, 2021, 32 (07) : 753 - 761
  • [46] Pathologic prognostic factors in stage I-III uterine carcinosarcoma treated with postoperative radiotherapy
    Rovirosa, Angeles
    Ascaso, Carlos
    Arenas, Meritxell
    Rios, Ivan
    del Pino, Marta
    Ordi, Jaume
    Morales, Javier
    Gascon, Marina
    Pahisa, Jaume
    Biete, Albert
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (02) : 329 - 334
  • [47] The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer
    Wang, Ren-Jie
    Song, Bao-Rong
    Peng, Jun-Jie
    Cai, Guo-Xiang
    Liu, Fang-Qi
    Wang, Ming-He
    Cai, San-Jun
    Xu, Ye
    HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 994 - 999
  • [48] Perineural invasion as a prognostic factor in patients with stage I-III rectal cancer - 5-year follow up
    Lalosevic, Milica Stojkovic
    Milovanovic, Tamara
    Micev, Marjan
    Stojkovic, Mirjana
    Dragasevic, Sanja
    Stulic, Milos
    Rankovic, Ivan
    Dugalic, Vladimir
    Krivokapic, Zoran
    Markovic, Aleksandra Pavlovic
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (05) : 592 - 600
  • [49] Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients
    Brerner, Troy M.
    Jacquemier, Jocelyne
    Charafe-Jauffret, Emmanuelle
    Viens, Patrice
    Birnbaum, Daniel
    Linke, Steven P.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (04) : 896 - 904
  • [50] Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study
    Xie, Hailun
    Wei, Lishuang
    Tang, Shuangyi
    Gan, Jialiang
    FRONTIERS IN ONCOLOGY, 2024, 14